The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses.
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Washington — The Justice Department announced Thursday that it has issued an order rescheduling certain marijuana products to a lower drug classification, while moving to expedite the process to ...
WASHINGTON (AP) — President Donald Trump's acting attorney general on Thursday signed an order reclassifying state-licensed medical marijuana as a less-dangerous drug, a major policy shift long sought ...
Marijuana had the same classification as heroin, LSD and others before being reclassified for lower potential for abuse Sign up for the Breaking News US email to get newsletter alerts in your inbox ...
The U.S. administration reclassified state-licensed or FDA approved marijuana products from a Schedule I to a Schedule III drug. This reclassification does not immediately change marijuana's legal ...
Using medical or recreational marijuana to ease symptoms of numerous mental health conditions doesn’t work, according to two new analyses of existing gold-standard research. Medical marijuana includes ...
The editorial board is a group of opinion journalists whose views are informed by expertise, research, debate and certain longstanding values. It is separate from the newsroom. See more of our ...
Aaron Navarro is a CBS News digital reporter. He covered the 2024 elections and was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. Washington — ...
Today is a good day for potheads, and a great one for the nation’s state-regulated marijuana businesses. In a historic move, the federal government will reclassify cannabis to a more lenient category.
Section 1. Purpose and Policy. Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of ...
RECOGNIZING AND IMPROVING KNOWLEDGE OF MEDICAL USES OF MARIJUANA AND CANNABIDIOL FOR PATIENTS AND DOCTORS: Today, President Donald J. Trump signed an Executive Order that will improve medical ...